Post Subject #224192   0 PPD is nasty, but would someone go through jbog 03/19/19 06:08:09 PM #224182   0 MRKR 10K is worth reading: rfj1862 03/19/19 12:15:18 PM #224181   0 ENTA is a sleeper entrant in the HBV DewDiligence 03/19/19 12:10:15 PM #224168   0 ...the key is [EOLS] are not racing to DewDiligence 03/19/19 09:47:21 AM #224112   0 Re: ADXS financing and news-flow speculation DewDiligence 03/17/19 08:14:04 PM #224095   0 RVNC—Eylea is indeed a pertinent benchmark for the DewDiligence 03/15/19 05:55:06 PM #224193   0 The 60-hour infusion at a specially licensed site DewDiligence 03/19/19 06:35:48 PM #224192   0 PPD is nasty, but would someone go through jbog 03/19/19 06:08:09 PM #224191   0 FDA approves SAGE’s Zulresso (brexanolone) for postpartum depression: DewDiligence 03/19/19 05:55:44 PM #224190   0 re: MRKR bladerunner1717 03/19/19 03:48:46 PM #224189   0 AFMD +7% on ROCK milestone payment from Roche. semi_infinite 03/19/19 02:54:17 PM #224188   0 Well, how much cash did ADXS forfeit by DewDiligence 03/19/19 02:46:52 PM #224186   0 How is the cashless swap only for a ignatiusrielly35 03/19/19 02:21:31 PM #224185   0 …with two more competitors being added over the DewDiligence 03/19/19 01:52:53 PM #224184   0 I have looked at the company and wonder rfj1862 03/19/19 01:29:08 PM #224183   0 I have looked at the company and wonder n4807g 03/19/19 01:13:44 PM #224182   0 MRKR 10K is worth reading: rfj1862 03/19/19 12:15:18 PM #224181   0 ENTA is a sleeper entrant in the HBV DewDiligence 03/19/19 12:10:15 PM #224180   0 Arrowhead looks interesting if overvalued. Their HBV program rfj1862 03/19/19 12:05:18 PM #224179   0 None of the new HBV agents is in DewDiligence 03/19/19 11:58:05 AM #224178   0 The most notable takeaway (IMO) is the Roche rfj1862 03/19/19 11:42:36 AM #224177   0 Re: Jefferies HBV forum yesterday DewDiligence 03/19/19 11:28:23 AM #224176   0 The RT002 FDA label for glabellar lines might DewDiligence 03/19/19 11:12:18 AM #224175   0 << duration is given as an approximate range, jmkobers 03/19/19 11:00:29 AM #224174   0 warning - this board is going to turn rfj1862 03/19/19 10:25:51 AM #224173   0 Quote: ...”the key is [EOLS] are not racing to biotech_researcher 03/19/19 10:21:33 AM #224172   0 Right—see the EOLS CC excerpt in #msg-147635889. DewDiligence 03/19/19 10:15:13 AM #224171   0 EOLS - From Minx at Investor Village: WID 03/19/19 10:13:18 AM #224170   0 EOLS—The need to wait for publication of their DewDiligence 03/19/19 10:05:43 AM #224169   0 they said they would launch in spring prior dewophile 03/19/19 10:01:55 AM #224168   0 ...the key is [EOLS] are not racing to DewDiligence 03/19/19 09:47:21 AM #224167   0 What do you make of EOLS' not having DewDiligence 03/19/19 09:40:45 AM #224166   0 Re: RVNC /specification of duration in label DewDiligence 03/19/19 09:39:51 AM #224165   0 Re: Jeuveau pricing DewDiligence 03/19/19 09:27:42 AM #224164   0 On the CC, management acknowledged that the actual dewophile 03/19/19 09:18:58 AM #224163   0 yes i saw that dewophile 03/19/19 09:16:15 AM #224162   0 Re: Jeuveau list price DewDiligence 03/19/19 08:40:10 AM #224161   0 The concise duration spec in the Botox FDA DewDiligence 03/19/19 08:34:39 AM #224160   0 RVNC/EOLS more color on pricing from the cc: dewophile 03/19/19 08:22:04 AM #224159   0 warning - this board is going to turn dewophile 03/19/19 07:59:40 AM #224158   0 AMRN: Further viewpoints/opinions/data from Reduce-It trial, presented at north40000 03/19/19 02:34:35 AM #224157   0 AMRN Vascepa was panned by a respected UCSF iwfal 03/18/19 08:19:15 PM #224156   0 Any thoughts on Mgta? ronpopeil 03/18/19 08:11:15 PM #224155   0 Dew. .. I should add ( I see Whalatane 03/18/19 08:05:05 PM #224154   0 Alphaeon won't have to worry about dilution unless DewDiligence 03/18/19 07:40:58 PM #224153   0 I'm sure EOLS will manage the company completely jbog 03/18/19 07:29:48 PM #224152   0 Right. The PR is in one of the DewDiligence 03/18/19 07:13:19 PM #224151   0 It seems ELOS reached outside the box to jbog 03/18/19 07:06:25 PM #224150   0 Thanks (eom). DewDiligence 03/18/19 05:58:43 PM #224149   0 See: https://investorshub.advfn.com/boards/replies.aspx?msg=147624581 GrthzGd 03/18/19 05:56:05 PM #224148   0 I feel like this has become the RVNC DewDiligence 03/18/19 05:43:56 PM #224147   0 What did she say about Vascepa? DewDiligence 03/18/19 05:40:25 PM #224146   0 Iwfal. No worries. Just me venting Repatha Whalatane 03/18/19 05:37:54 PM #224145   0 PTE -15% on SEC investigation: DewDiligence 03/18/19 05:27:48 PM #224144   0 Price targets from sell-side analysts have little or DewDiligence 03/18/19 05:19:50 PM #224143   0 EOLS—Jeuveau's US list price is $610 per 100U DewDiligence 03/18/19 05:13:32 PM Post Subject

© 2019 InvestorsHub.com, Inc.